Published in Indian J Endocrinol Metab on October 01, 2011
Safety and efficacy of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Japanese patients with hypertension and renal dysfunction. Hypertens Res (2015) 0.86
Subjective Social Status and Cardiovascular Reactivity: An Experimental Examination. Front Psychol (2016) 0.75
Evidence that remodeling of insular cortex neurovascular unit contributes to hypertension-related sympathoexcitation. Physiol Rep (2017) 0.75
Systolic blood pressure but not electrocardiogram QRS duration is associated with heart rate variability (HRV): a cross-sectional study in rural Australian non-diabetics. Clin Hypertens (2017) 0.75
microRNA in Cardiovascular Aging and Age-Related Cardiovascular Diseases. Front Med (Lausanne) (2017) 0.75
The Microbiome and Blood Pressure: Can Microbes Regulate Our Blood Pressure? Front Pediatr (2017) 0.75
The role of macrophages in skin homeostasis. Pflugers Arch (2017) 0.75
The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (1980) 40.02
A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (1988) 27.60
Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature (1988) 18.41
A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci (1981) 6.39
International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev (2000) 6.30
Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun (1993) 4.32
B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation (2002) 4.30
Flow-induced release of endothelium-derived relaxing factor. Am J Physiol (1986) 3.51
Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial. JAMA (2004) 3.39
Cardiovascular disease in non-Western countries. N Engl J Med (2004) 3.12
Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med (1972) 2.99
Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord (1998) 2.81
Chronic leptin infusion increases arterial pressure. Hypertension (1998) 2.78
Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol (1998) 2.52
Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev (2000) 2.52
Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension (1986) 2.30
Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology (1992) 2.06
Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation. Endocr Rev (2003) 1.97
Characterization of a coronary vasoconstrictor produced by cultured endothelial cells. Am J Physiol (1985) 1.97
Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. J Hypertens (2008) 1.90
Angiotensin AT1/AT2 receptors: regulation, signalling and function. Blood Press (2003) 1.79
The mammalian tachykinin receptors. Gen Pharmacol (1995) 1.74
Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum. J Biol Chem (1995) 1.73
Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest (2000) 1.68
Pivotal role of nitric oxide in the control of blood pressure after leptin administration. Diabetes (1999) 1.64
Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology, and therapeutic potentials. Endocr Rev (1996) 1.63
Adiponectin: from obesity to cardiovascular disease. Obes Rev (2009) 1.50
Effect of salt intake on endothelium-derived factors in a group of patients with essential hypertension. Clin Sci (Lond) (2001) 1.44
Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension (1996) 1.37
Immunoreactive adrenomedullin in human plasma. FEBS Lett (1994) 1.18
A friend within the heart: natriuretic peptide receptor signaling. J Clin Invest (2003) 1.16
Flow-mediated and reflex changes in large peripheral artery tone in humans. Circulation (1989) 1.16
AT(1) and AT(2) receptors in the kidney: role in disease and treatment. Am J Kidney Dis (2000) 1.13
Role of endothelin-1 in clinical hypertension: 20 years on. Hypertension (2008) 1.13
Impaired endothelium-dependent relaxations in hypertensive resistance arteries involve cyclooxygenase pathway. Am J Physiol (1990) 1.04
Cell type-specific angiotensin II-evoked signal transduction pathways: critical roles of Gbetagamma subunit, Src family, and Ras in cardiac fibroblasts. Circ Res (1998) 1.03
Franz Volhard Lecture. Renin-angiotensin system: a dual tissue and hormonal system for cardiovascular control. J Hypertens Suppl (1992) 1.00
Phosducin influences sympathetic activity and prevents stress-induced hypertension in humans and mice. J Clin Invest (2009) 0.98
Sympathovagal balance is major determinant of short-term blood pressure variability in healthy subjects. Am J Physiol (1999) 0.98
Gender differences in the relationship between leptin, insulin resistance and the autonomic nervous system. Regul Pept (2006) 0.97
Role of endothelin-1 in hypertension. Curr Hypertens Rep (2003) 0.96
Resting metabolic rate and substrate use in obesity hypertension. Hypertension (2000) 0.95
TNF-alpha induced bronchial vasoconstriction. Am J Physiol Heart Circ Physiol (2000) 0.95
Renin and prorenin receptor in hypertension: what's new? Curr Hypertens Rep (2011) 0.94
Increased activity of constitutive nitric oxide synthase in cardiac endothelium in spontaneous hypertension. Circulation (1995) 0.93
Angiotensin II type 2 receptor stimulation of neuronal K+ currents involves an inhibitory GTP binding protein. Am J Physiol (1994) 0.93
Urinary excretion rate of endothelin-1 in patients with essential hypertension and salt sensitivity. Kidney Int (1994) 0.92
Adiponectin and vascular properties in obese patients: is it a novel biomarker of early atherosclerosis? Int J Obes (Lond) (2009) 0.91
Elevated plasma levels of human adrenomedullin in cardiovascular, respiratory, hepatic and renal disorders. Clin Sci (Lond) (1997) 0.91
Dose-dependent systemic and regional hemodynamic effects of calcitonin gene-related peptide. Am J Med Sci (1989) 0.86
Effect of angiotensin II type 1 receptor antagonism on endothelial function: role of bradykinin and nitric oxide. J Hypertens Suppl (2006) 0.86
Rationale for use of an exercise end point and design for the ADVANCE (A Dose evaluation of a Vasopressin ANtagonist in CHF patients undergoing Exercise) trial. Am Heart J (2003) 0.85
Conivaptan: YM 087. Drugs R D (2004) 0.84
Hemodynamic action of calcitonin gene-related peptide in the isolated rat heart. Life Sci (1987) 0.82
Effects of endothelin on regional blood flows in squirrel monkeys. J Pharmacol Exp Ther (1989) 0.82
Angiotensin receptor blockers: evidence for preserving target organs. Clin Cardiol (2001) 0.81
The sympathoadrenal system in the maintenance of elevated arterial pressure. J Cardiovasc Pharmacol (1984) 0.81
Interactions between the sympathetic nervous system and the cardiac natriuretic peptide system. Cardiovasc Res (2004) 0.80
The role of nitric oxide in the regulation of coronary vascular resistance in arterial hypertension: comparison of normotensive and spontaneously hypertensive rats. J Cardiovasc Pharmacol (1992) 0.80
Acute simultaneous stimulation of nitric oxide and oxygen radicals by angiotensin II in humans in vivo. J Cardiovasc Pharmacol (1999) 0.79
Action of angiotensin receptor subtypes on the renal tubules and vasculature: implications for volume homeostasis and atherosclerosis. Miner Electrolyte Metab (1998) 0.79
Impaired baroreflex sensitivity and sympathovagal balance in syndrome X. Am J Cardiol (1998) 0.79
Sympathetic activation and contribution of genetic factors in hypertension with neurovascular compression of the rostral ventrolateral medulla. J Hypertens (1999) 0.77
Reduction in resting metabolic rate and ratio of plasma leptin to urinary nitric oxide: influence on obesity-related hypertension. Isr Med Assoc J (2002) 0.77
Sympathoadrenal activity, catecholamines, and the pathogenesis of vasculopathic hypertensive target-organ damage. Am J Hypertens (1989) 0.76
Elevated endothelin-1 plasma concentration in patients with essential hypertension. J Cardiovasc Risk (1994) 0.76
The cellular basis of angiotensin converting enzyme mRNA expression in rat heart. Basic Res Cardiol (1996) 0.76
Conivaptan Yamanouchi. Curr Opin Investig Drugs (2005) 0.76
Bilateral maxillary brown tumours as the first presentation of primary hyperparathyroidism. Oral Maxillofac Surg (2008) 1.48
Effects of pioglitazone on menstrual frequency, hyperandrogenism and insulin resistance in adoloscents and young adults with polycystic ovary syndrome. J Pediatr Adolesc Gynecol (2009) 1.10
A prospective assessment of dietary patterns in Muslim subjects with type 2 diabetes who undertake fasting during Ramadan. Indian J Endocrinol Metab (2012) 1.00
Fatal hypoglycemia with levofloxacin use in an elderly patient in the post-operative period. Langenbecks Arch Surg (2008) 0.76
Idiopathic ketotic hypoglycemia presenting as febrile seizures. Indian J Pediatr (2010) 0.75
Visual vignette. Albright-McCune syndrome. Endocr Pract (2007) 0.75
Visual vignette. Solitary sacral metastasis from a malignant paraganglioma. Endocr Pract (2008) 0.75
Levofloxacin and hypoglycemia. Clin Infect Dis (2008) 0.75